The Green Organic Dutchman: The Next Organic Superstar


“The Green Organic Dutchman Holdings Ltd. (“TGOD”) is first and foremost a shareholder driven company, managed and directed by its shareholders.

Our goal is to build a business that is not only resistant to financial market fluctuations, but also to the uncharted challenges that a new company in a brand new industry will undoubtedly face.

By successfully executing on our business plan we have the opportunity to deliver exponential near term growth & cash flow. We understand that setting such aggressive goals inevitably comes with serious risks, such as man power, project management, execution, available capital, proper fiscal controls, responsibility and many others.

It is our view that by building a well balanced and multidisciplinary team who can leverage the experience, purchasing power and sector specific expertise of two multibillion dollar companies as our strategic partners. We will be able to de-risk the project and provide shareholders with a superior rate of return based on a platform of long-term growth, stability and profitability”





The Organic Cannabis Market


58% of consumers prefer organic produce, cannabis is medicine and is no different.





The Dutchman’s sales strategy



Significant demand from fellow LP’s for organic product. Current offers as high as $5.00g. (We feel this is due to current market conditions). Forward sale agreements allow for immediate revenue in early stages of development while retail following is being built No fulfilment and minimal shipping costs Wholesale platform operates with a significantly reduced overhead based on shipping and fulfilment




Image result for wholesale icon

Patient acquisition

As patient acquisition growth increases, our sales will shift from wholesale to much more profitable retail Based on industry data, patients demand quality and pay a premium price for organic products over non-organic products Developing strategic partnerships with cannabis clinic networks, pain clinics, and veteran networks, these partnerships do NOT involve a 20% fee




Image result for acquisition icon


In discussion with significant distribution partners: LPs, drug stores, pharma companies, liquor stores, & dispensaries for recreational Creates instant distribution to the much more profitable retail/recreational market Management team has significant experience in structuring large JV transactions If you appreciate our methodology of growing an established team and partnerships to build out our expansion plan, you will be equally impressed with our team building and partnerships on our patient acquisition strategy

Image result for joint venture icon





Rob Anderson—CEO and Director

Rob Anderson brings 20 years of experience working with micro-cap companies in a broad range of sectors. He spent 12 years in the Canadian brokerage Industry with one of Canada’s leading independent firms. Anderson has financed hundreds of micro-cap companies he has developed a unique identification & selection process which has led to an impressive track record of success, with multiple companies reaching market valuations in excess of $1 billion. He is a strong advocate for retail shareholders, believes in working with management by developing a staged financing approach to addressing a company’s capital requirements, as well as advising on the development of business plans, recruiting management, negotiating transactions, joint ventures, and supporting management during the company’s growth cycle.

Jeff Paikin—Chairman of the Board

Jeff Paikin is the president and founder of New Horizon Development Group. In 2013 he was named RBC Distinguished Citizen of the Year for Hamilton. He is very active in the home building industry as a past president of the Hamilton Halton Home Builders’ Association and a former board member of both the Ontario Home Builders’ Association and the Canadian Home Builders’ Association. Paikin is a member of the Hamilton Tiger- Cats advisory board and the Hamilton Bulldogs Community Foundation board, as well as being the current Chair of the Hillfield Strathallan College Capital Campaign and past Chair of the board of both Hillfield Strathallan College and the Canadian Accredited Independent Schools (

Ian Wilms—Director

Ian Wilms is an executive with over 25 years of global, business experience leading successful entrepreneurial and corporate ventures. As an executive with IBM for 14 years, he led and managed sales and operational teams across North and South America. Wilms is a certified Client Executive from the Harvard Business School and a graduate of McMaster University in Hamilton. He was appointed Chairman of the Calgary Police Commission in 2005 and elected President of the Canadian Association of Police Boards in 2006. Wilms also served 10 years with the Canadian Military as an Officer LT (N) in the Naval Reserve. Currently, he is the Vice President of Sales and Marketing for Energy Advantage, a leader in helping corporations become energy efficient and reduce their carbon footprint.

Scott Skinner—Co-Founder, Director and COO

Scott Skinner engineered, designed and oversaw the construction of the Green Organic Dutchman’s production facility. This state-of-the-art facility now houses 36 varieties of cannabis. His current ongoing projects are the research and development of LED based Light Spectrum Optimization Technology for best cannabis production yields along with the development of Tissue Culture Propagation Protocols for the rapid cloning of cannabis plants.

Dave Doherty—Director

Dave Doherty brings over 20 years of investment and finance experience to the company. He assists with financings, identifying acquisition targets, develop strategic plans and, support operations as well as implementing exit strategies. Doherty was an investment adviser with Canaccord Capital, Canada’s largest independent securities dealer covering the North American capital markets specializing in developing, structuring and financing venture and growth companies in the Resource sector. Doherty has sat on numerous boards including Organigram Holdings and presently is on the Board of Saber Capital, to be renamed Emblem Cannabis. He holds a degree from Simon Fraser University, with a major in finance. 

Jeannette Vandermarel­—Co-Founder

Jeanette Vandermarel grew up on a commercial scale fruit farm in Southern Ontario and learned about agricultural business management. She later became a Registered Nurse and worked in Paediatric Critical Care as a team leader and charge nurse. In 2012, Vandermarel completed the Case Management/Patient Advocacy program through McMaster University in Hamilton Ontario. Her daughter Breanne passed away in 2003 as a result of Dravet Syndrome, a severe seizure disorder. Breanne spent most of her 8 years of life on powerful anticonvulsant drugs that did little to control her seizures and unfortunately caused serious side effects. She was never given cannabis. Around 2008, anecdotal reports began showing potential for cannabis based medicines. Vandermarel, while caring for children with severe seizures in the Paediatric ICU became aware that some children were having great seizure control by using cannabis medicines. Her passion for helping children was the basis for co-founding The Green Organic Dutchman.

Marc Cernovitch—President

Marc Cernovitch brings over 20 years of investment and corporate finance experience to the company. He studied Economics at McGill University and has focused on corporate development, funding and building companies primarily in the resource and energy technology fields. He has a strong background in corporate governance and finance. For the past 20 years, Cernovitch has been providing capital markets advisory services to companies across both public and private sectors. In this capacity, he has served as a director and advisor to numerous small and mid-cap companies contemplating and/or executing financing and M&A transactions.

Brett Allan—Vice-President Investor Relations

Brett Allan brings 10 years of public markets and corporate finance experience to the company. Prior to co-founding GEMTEC International, he served as Dir. Capital Markets for Organigram Inc. and raised approximately $13 million while helping to list the company on the TSX Venture. Allan is the Founder and CEO of Apex Capital Corp., a boutique capital markets firm which provides capital markets and investor relations services to a number of public companies and has raised in excess of $120 million since 2010.

Lola Millerman—Manager of Quality Assurance

Lola Millerman graduated from UBC with a Bachelor of Science degree in Biology. She started her career in the forestry industry, working in a mycology research laboratory at FP Innovations. Millerman then proved herself to be an asset to Nestle Canada, while holding the position of senior microbiologist and later promoted to the Factory Hygienist position, where she worked on compliance with CFIA regulations, as well as Nestle Quality Assurance Compliance standards of Good Manufacturing Practices and Good Laboratory Practices. Her role also included overseeing microbiological laboratory operations.


Issued and Outstanding

# of shares % of shares
Green Organic Founders** 11,500,000 12.4%
Lines Founder Group** 24,750,000 26.7%
Management Team 21,450,000 23.1%
Retail Investors 35,050,000 37.8%
Total 92,800,000 100%


Cash, Debt, Warrants, Options

Cash $12,500,000
Options Outstanding 9,280,000
Warrants Outstanding NIL
Debt  NIL



Peer Comparison

Acres Sq Ft expansion Current Capacity Funded Capacity Market Cap
Hydropothecary 65 42,000 600 3,000 270 mil*
Marican 100 300,000 625 1,350 253 mil*
Cronos 90 170,00 4,495 18,255 301 mil*
Supreme 7 342,000 1,200 10,000 275 mil*
TGOD pre money 100 125,000 + 20,000 1,000 5,000 106 mil
TGOD post money 100 125,000 + 20,000 1,000 14,000 116 mil

*Hydropothecary – 60,198,546 s/o @ $4.50 = $270MM via proposed qualifying transaction press release 11/17/16
*MariCann – 89,059,000 s/o @ $2.85 = $253MM via Company Term Sheet 01/26/17
*Cronos – 122,680,133 s/o @ $2.46 = $301MM via Public Company documents
*Supreme – 154,738,782 s/o @ $1.78 = $275MM via Public Company documents 

Add a Comment

Your email address will not be published.